3 Things You Need to Know if You Buy AbbVie Stock Today
One of the world's top biopharma companies, (NYSE: ABBV) is a fairly complicated stock to approach as an independent investor. Aside from the scientific chops needed to evaluate the quality of its pipeline and the competitive landscape it operates in, you need to understand a suite of governance and business matters before buying the stock.
Let's take a moment and identify three primary areas of interest, so you're better equipped to determine whether the company is a smart buy for you.
First, pay attention to changes in executive leadership, especially when a highly effective leader is departing.
Source Fool.com
AbbVie Inc. Stock
€175.30
0.030%
The stock is an absolute favorite of our community with 34 Buy predictions and no Sell predictions.
As a result the target price of 180 € shows a slightly positive potential of 2.68% compared to the current price of 175.3 € for AbbVie Inc..
